Two Strategies Help Prevent CMV Disease in Transplant Patients

This article originally appeared here.
Share this content:
Two Strategies Help Prevent CMV Disease in Transplant Patients
Two Strategies Help Prevent CMV Disease in Transplant Patients

TUESDAY, Dec. 30, 2014 (HealthDay News) -- For liver transplant recipients, universal prophylaxis and preemptive strategies (using ganciclovir or valganciclovir) are similarly effective for preventing cytomegalovirus (CMV) disease (CMD), according to research published online Dec. 17 in the American Journal of Transplantation.

Khalid Mumtaz, M.D., from The Ohio State University in Columbus, and colleagues conducted a systematic review and meta-analysis to examine the efficacy of universal prophylaxis and preemptive strategies for preventing CMD in liver transplant recipients. The authors assessed CMD as the primary outcome, while secondary outcomes included acute cellular rejection, graft loss, and mortality. An indirect comparison of the studies was performed due to the heterogeneity of comparative studies. Data were included for 32 studies involving 2,456 liver transplant recipients.

The researchers found that most studies had a low risk of bias. CMD was 10 percent with universal prophylaxis and 7 percent with preemptive strategies, regardless of donor/recipient CMV sero-status (mean difference, 2.6; P = 0.34). Between the strategies, acute cellular rejection and graft loss were also similar. Regardless of donor/recipient sero-status, graft loss was significantly lower in the universal prophylaxis group.

"In indirect comparison, the incidence of CMD, acute cellular rejection, and mortality in liver transplant recipients [was] similar with two strategies," the authors write. "Trials comparing the two strategies directly are needed."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

E. Coli Found in Water at Tennessee Ziplining Facility

<i>E. Coli</i> Found in Water at Tennessee Ziplining ...

One visitor to the CLIMB Works Zipline Canopy Tour in Gatlinburg tested positive for norovirus and E. coli

FDA: Illnesses Tied to Fresh Crab Meat Imported From Venezuela

FDA: Illnesses Tied to Fresh Crab Meat Imported ...

Illnesses appear to be caused by Vibrio parahaemolyticus bacteria

FDA Approves First Drug to Treat Smallpox

FDA Approves First Drug to Treat Smallpox

New treatment offers additional option should smallpox ever be used as a bioweapon

is free, fast, and customized just for you!




Already a member?

Sign In Now »